A Master Protocol to Evaluate the Long-Term Safety of Pirtobrutinib
Categories (click each to see list of all clinical trials associated with that category): Lymphoma/CLL (ONC)
Current Status: Open
Phase: IV (Cancer Control)
Principal Investigator: Lunning, Matthew
Contact Information:
Katie Bourret
kbourret@unmc.edu
Summary
Primary
To evaluate the long-term safety of pirtobrutinib
Secondary
To evaluate the overall survival of the participant